Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 953-961

  Kim, Ji Tae ^a,b   Li, Jing ^a,b   Jang, Eun Ryoung ^b   Gulhati, Pat ^a,b,c   Rychahou, Piotr G ^a,b   Napier, Dana L ^a,d   Wang, Chi ^a   Weiss, Heidi L ^a   Lee, Eun Y ^a,d   Anthony, Lowell ^b   Townsend, Courtney M ^e   Liu, Chunming ^a,b   Evers, B Mark ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; HISTONE H3; LYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ANCHORAGE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EPIGENETICS; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MUTATIONAL ANALYSIS; NEUROENDOCRINE TUMOR; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; TUMOR CELL; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AXIN PROTEIN; BETA CATENIN; CELL LINE, TUMOR; CELL NUCLEUS; CPG ISLANDS; CYTOPLASM; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION; GENES, APC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, NUDE; MUTATION; NEUROENDOCRINE TUMORS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS;

EID: 84877118579     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt018     Document Type: Article

References (50)

1. Modlin,I.M. et al. (2005) Current status of gastrointestinal carcinoids. Gastroenterology, 128, 1717-1751.
2. Valentino,J. et al. (2011) Recent advances in the diagnosis and treatment of gastrointestinal carcinoids. Adv. Surg., 45, 285-300.
3. Modlin,I.M. et al. (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer, 97, 934-959.
4. Maggard,M.A. et al. (2004) Updated population-based review of carcinoid tumors. Ann. Surg., 240, 117-122.
5. Kohler,B.A. et al. (2011) Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J. Natl Cancer Inst., 103, 714-736.
6. Bowen,K.A. et al. (2009) An analysis of trends and growth factor receptor expression of GI carcinoid tumors. J. Gastrointest. Surg., 13, 1773-1780.
7. Clevers,H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
8. Klaus,A. et al. (2008) Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer, 8, 387-398.
9. MacDonald,B.T. et al. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 17, 9-26.
10. Ying,Y. et al. (2009) Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. Epigenetics, 4, 307-312.
11. Esteller,M. et al. (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res., 60, 4366-4371.
12. Koch,A. et al. (2004) Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. J. Pathol., 204, 546-554.
13. Tseng,R.C. et al. (2008) Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type betacatenin nuclear accumulation in lung tumorigenesis. Oncogene, 27, 4488-4496.
14. Suzuki,H. et al. (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet., 36, 417-422.
15. Mazieres,J. et al. (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res., 64, 4717-4720.
16. Aguilera,O. et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene, 25, 4116-4121.
17. Urakami,S. et al. (2006) Combination analysis of hypermethylated Wntantagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin. Cancer Res., 12, 2109-2116.
18. Sato,H. et al. (2007) Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis, 28, 2459-2466.
19. Nojima,M. et al. (2007) Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene, 26, 4699-4713.
20. Yu,J. et al. (2009) Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer, 115, 49-60.
21. Licchesi,J.D. et al. (2010) Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene, 29, 5923-5934.
22. Shilatifard,A. (2006) Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem., 75, 243-269.
23. Zhang,Y. et al. (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev., 15, 2343-2360.
24. Richards,E.J. et al. (2002) Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell, 108, 489-500.
25. Fuks,F. (2005) DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev., 15, 490-495.
26. Wozniak,R.J. et al. (2007) 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene, 26, 77-90.
27. Lee,S.H. et al. (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene, 28, 184-194.
28. Fujimori,M. et al. (2001) Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res., 61, 6656-6659.
29. Su,M.C. et al. (2006) Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor. Ann. Surg. Oncol., 13, 1604-1609.
30. Evers,B.M. et al. (1991) Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology, 101, 303-311.
31. Vedadi,M. et al. (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol., 7, 566-574.
32. Yu,T. et al. (2012) Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer. J. Biol. Chem., 287, 3760-3768.
33. Deng,G. et al. (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res., 59, 2029-2033.
34. Gulhati,P. et al. (2012) Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic Kras and Pik3ca. Carcinogenesis, 33, 1782-1790.
35. Fahrner,J.A. et al. (2002) Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res., 62, 7213-7218.
36. Nguyen,C.T. et al. (2002) Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res., 62, 6456-6461.
37. Rice,J.C. et al. (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell, 12, 1591-1598.
38. Kikuchi,A. (2003) Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci., 94, 225-229.
39. Austinat,M. et al. (2008) Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol. Cancer, 7, 21.
40. Hahnloser,D. et al. (2003) The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiol. Biomarkers Prev., 12, 1023-1028.
41. Rozek,L.S. et al. (2006) APC E1317Q is not associated with colorectal cancer in a population-based case-control study in Northern Israel. Cancer Epidemiol. Biomarkers Prev., 15, 2325-2327.
42. Hall,M.J. et al. (2009) Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Ann. Oncol., 20, 1517-1521.
43. Gayther,S.A. et al. (1995) Rapid detection of rare variants and common polymorphisms in the APC gene by PCR-SSCP for presymptomatic diagnosis and showing allele loss. J. Med. Genet., 32, 568-571.
44. Davies,S.M. et al. (1994) Frequent polymorphism in exon 15 of the adenomatous polyposis coli gene. Hum. Genet., 93, 329-330.
45. Veeck,J. et al. (2006) Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene, 25, 3479-3488.
46. Chim,C.S. et al. (2006) Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor. Leukemia, 20, 907-909.
47. Bachman,K.E. et al. (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell, 3, 89-95.
48. Jiang,X. et al. (2008) DACT3 is an epigenetic regulator of Wnt/betacatenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell, 13, 529-541.
49. Chen,M.W. et al. (2010) H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res., 70, 7830-7840.
50. Huang,J. et al. (2010) G9a and Glp methylate lysine 373 in the tumor suppressor p53. J. Biol. Chem., 285, 9636-9641.